Antengene presents anti-CLDN18.2 ATG-022 for the treatment of gastric cancer April 20, 2022 No Comments
Cellectis details activity of allogeneic CAR-T cells targeting CD20 and CD22: UCART20x22 April 19, 2022 No Comments
Anti-CLDN18.2/CD47 antibody PT-886 shows antitumoral activity in model of pancreatic cancer April 19, 2022 No Comments
New platform for rapid development of patient-specific APECs for ovarian carcinoma April 19, 2022 No Comments
RSS